GlassScriptPhysician profile
Jennie Ou
NPI 1972921401
$1,508.55
in general payments reported to CMS, 2019-2025
21 companies · $17.81 in 2025
The $17.81 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $250 · 2021: $584 · 2022: $127 · 2023: $141 · 2024: $53.88 · 2025: $17.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $645.17 | 2020-2023 | |
| Minerva Surgical, INC | $117.07 | 2019 | |
| Gen-Probe Sales & Service, INC. | $110.71 | 2022 | |
| Lupin INC. | $85.21 | 2019-2021 | |
| Acessa Health INC. | $84.58 | 2019 | |
| Organon LLC | $59.74 | 2021-2025 | Nexplanon, Jada System |
| Coopersurgical, INC. | $49.03 | 2021-2024 | Paragard T 380a |
| Millicent US INC | $43.95 | 2019-2020 | |
| Astellas Pharma US INC | $41.94 | 2021 | |
| Therapeuticsmd, INC. | $37.71 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $33.61 | 2020-2021 | |
| Coloplast Corp | $33.41 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.86 | 2021 | |
| Mayne Pharma Commercial LLC | $22.47 | 2021 | |
| Vertical Pharmaceuticals, LLC | $20.79 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.18 | 2019 | |
| Agile Therapeutics, INC. | $17.06 | 2021 | |
| Medtronic, INC. | $16.86 | 2024 | Truclear |
| Amag Pharmaceuticals, INC. | $16.70 | 2019 | |
| Evofem Biosciences, INC. | $15.25 | 2021 | |
| Myovant Sciences INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennie Ou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.